Zymeworks Q3 EPS $(0.41) Beats $(0.47) Estimate
Portfolio Pulse from Benzinga Newsdesk
Zymeworks (NASDAQ:ZYME) reported Q3 losses of $(0.41) per share, beating the analyst consensus estimate of $(0.47) by 12.77 percent.
November 07, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zymeworks reported Q3 losses of $(0.41) per share, beating the analyst consensus estimate by 12.77 percent.
Zymeworks reported better than expected Q3 earnings, which could lead to a positive market reaction and potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100